Although 5-Aza-2-dc treatment led to minor increase of RARβ mRNA in NSCLC cells, it had no effect on the level of GPRC5A mRNA, consistent with the observation of no DNA methylation at the GPRC5A promoter. This evidence concerns the gene GPRC5A and non-small cell lung carcinoma.